The new orally active immunoregulator laquinimod (ABR-215062) effectively inhibits development and relapses of experimental autoimmune encephalomyelitis

✍ Scribed by Charlott Brunmark; Anna Runström; Lennart Ohlsson; Birgitta Sparre; Thomas Brodin; Mikael Åström; Gunnar Hedlund

• Book ID: 114137715
• Publisher: Elsevier Science
• Year: 2002
• Tongue: English
• Weight: 438 KB
• Volume: 130
• Category: Article
• ISSN: 0165-5728
• DOI: 10.1016/s0165-5728(02)00225-4